W. Zingg et al., Detection and quantification of cell-free Epstein-Barr virus by polymerasechain reaction and subsequent DNA enzyme immunoassay, J VIROL MET, 79(2), 1999, pp. 141-148
Amplification by polymerase chain reaction and subsequent DNA enzyme immuno
assay (DEIA) were employed to determine the number of genome equivalents of
cell-free Epstein-Barr virus (EBV) DNA in peripheral blood. The assay dete
cted cell-free EBV DNA in the serum of 14 out of is patients with primary,
productive EBV infection (sensitivity 77.7%) but not in healthy EBV carrier
s with latent infection (specificity 100%). Our assay has the potential for
a clinical diagnostic tool to monitor patients at risk for EBV reactivatio
n and productive infection with subsequent EBV-induced lymphoproliferative
diseases. (C) 1999 Elsevier Science B.V. All rights reserved.